Letrozole /GnRH Antagonist Protocol in Women Over 40 Years Undergoing ICSI Cycle
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study To compare the clinical and laboratory outcomes of two ovarian
stimulation protocols (standard GnRH antagonist protocol and aromatase inhibitor/ antagonist
protocol) in women (40-44) years undergoing ICSI cycle.